Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pancreatic carcinoma
|
322 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.700 | 1.000 | 2 | 2014 | 2018 | ||||
Prostate specific antigen measurement
|
95 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||
Malignant Neoplasms
|
1641 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.100 | 0.900 | 10 | 2010 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.100 | 0.900 | 10 | 2010 | 2018 | ||||
Carcinoma of lung
|
1204 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.090 | 1.000 | 9 | 2009 | 2018 | ||||
Malignant neoplasm of lung
|
1142 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.090 | 1.000 | 9 | 2009 | 2018 | ||||
Primary malignant neoplasm of lung
|
981 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.090 | 1.000 | 9 | 2009 | 2018 | ||||
Bladder Neoplasm
|
281 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.040 | 1.000 | 4 | 2011 | 2018 | ||||
Breast Carcinoma
|
2793 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.040 | 0.750 | 4 | 2013 | 2018 | ||||
Carcinoma of bladder
|
309 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.040 | 1.000 | 4 | 2011 | 2018 | ||||
Liver carcinoma
|
942 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.040 | 1.000 | 4 | 2013 | 2017 | ||||
Malignant neoplasm of breast
|
3417 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.040 | 0.750 | 4 | 2013 | 2018 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.040 | 1.000 | 4 | 2011 | 2018 | ||||
Adenocarcinoma
|
168 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.020 | 1.000 | 2 | 2013 | 2014 | ||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.020 | 0.500 | 2 | 2016 | 2019 | ||||
Neoplasms
|
1644 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.020 | 1.000 | 2 | 2017 | 2017 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||
Renal Cell Carcinoma
|
288 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.020 | 0.500 | 2 | 2016 | 2019 | ||||
Adult Diffuse Large B-Cell Lymphoma
|
46 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Adult Glioblastoma
|
98 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Benign Prostatic Hyperplasia
|
91 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
cervical cancer
|
268 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Cervix carcinoma
|
283 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Childhood Glioblastoma
|
98 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Childhood Leukemia
|
140 | 0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 | 0.010 | 1.000 | 1 | 2011 | 2011 |